Neutralization of IL-6 and suppression of the signal transducer and activator of transcription 3 signaling in the brains of AD mouse models reduced memory impairment and peripheral glucose intolerance and normalized plasma levels of IL-6. This evidence concerns the gene IL6 and Alzheimer disease.